Author:
Qu Jiahao,Sumali Brian,Lee Ho,Terai Hideki,Ishii Makoto,Fukunaga Koichi,Mitsukura Yasue,Nishimura Toshihiko
Abstract
AbstractSince 2019, a large number of people worldwide have been infected with severe acute respiratory syndrome coronavirus 2. Among those infected, a limited number develop severe coronavirus disease 2019 (COVID-19), which generally has an acute onset. The treatment of patients with severe COVID-19 is challenging. To optimize disease prognosis and effectively utilize medical resources, proactive measures must be adopted for patients at risk of developing severe COVID-19. We analyzed the data of COVID-19 patients from seven medical institutions in Tokyo and used mathematical modeling of patient blood test results to quantify and compare the predictive ability of multiple prognostic indicators for the development of severe COVID-19. A machine learning logistic regression model was used to analyze the blood test results of 300 patients. Due to the limited data set, the size of the training group was constantly adjusted to ensure that the results of machine learning were effective (e.g., recognition rate of disease severity > 80%). Lymphocyte count, hemoglobin, and ferritin levels were the best prognostic indicators of severe COVID-19. The mathematical model developed in this study enables prediction and classification of COVID-19 severity.
Funder
The study was funded by Keio Research Global Institute
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl. J. Med. 382(8), 727–733 (2020).
2. Xu, Z. et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 8(4), 420–422 (2020).
3. Naming the coronavirus disease (COVID-19) and the virus that causes it, World Health Organization. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it (April, 7, 2020).
4. COVID-19 MAP, Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html (April, 7, 2020).
5. Gandhi, R. T. et al. Mild or moderate Covid-19. N Engl. J. Med. 383(18), 1757–1766 (2020).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献